Insulin Therapy for Hospitalized Patients with Blood Glucose 200-300 mg/dL
Yes, insulin should be initiated or intensified for hospitalized patients with blood glucose levels between 200-300 mg/dL, confirmed on two occasions within 24 hours. 1
Treatment Threshold and Initiation
The American Diabetes Association 2025 guidelines establish a clear threshold: insulin and/or other glucose-lowering therapies should be initiated or intensified for persistent hyperglycemia starting at ≥180 mg/dL (confirmed twice within 24 hours) for both critically ill and non-critically ill hospitalized patients. 1 Since your patient's glucose is 200-300 mg/dL, this clearly exceeds the treatment threshold and warrants intervention.
Recommended Insulin Regimen Based on Severity
For patients with moderate hyperglycemia (201-300 mg/dL), the Lancet Diabetes & Endocrinology guidelines recommend:
- Basal insulin regimen starting at 0.2-0.3 U/kg per day 1
- Add correction doses with rapid-acting insulin before meals or every 6 hours 1
- This approach is appropriate for patients on multiple antidiabetic agents at home or those with insulin total daily dose <0.6 U/kg per day 1
Key Distinction from Severe Hyperglycemia
Patients with glucose >300 mg/dL require a more intensive basal-bolus regimen (half basal, half bolus insulin), whereas your patient in the 200-300 mg/dL range can be managed with basal insulin plus correction doses. 1
Avoiding Common Pitfalls
Do not use sliding scale insulin alone in patients with known diabetes, as this approach is associated with clinically significant hyperglycemia and has been condemned in clinical guidelines. 1 Sliding scale insulin treats hyperglycemia only after it occurs rather than preventing it. 1
Exception for Sliding Scale Use
Sliding scale insulin alone may be appropriate only for:
- Patients without diabetes who have mild stress hyperglycemia 1
- Patients with good metabolic control on oral agents at home who cannot maintain glucose <180 mg/dL 1
Hypoglycemia Risk Management
The basal-plus approach (basal insulin with correction doses) carries lower hypoglycemia risk compared to full basal-bolus regimens, making it ideal for the 200-300 mg/dL range. 1
Reduce starting doses to 0.15 U/kg per day in patients at high risk for hypoglycemia: 1
- Elderly or frail patients
- Those with acute kidney injury
- Patients with poor oral intake
Alternative Considerations
For patients with mild hyperglycemia (<200 mg/dL) who are insulin-naive or on minimal home insulin, low-dose basal insulin or oral antidiabetic drugs with correction doses would be appropriate. 1 However, your patient exceeds this threshold.
The basal insulin approach with correction doses provides effective glycemic control while minimizing the complexity and hypoglycemia risk associated with more intensive regimens, making it the optimal choice for hospitalized patients in the 200-300 mg/dL range. 1